ADAR1 Capital Management »

Astria Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $66k 4.7k 14.08
2023-12-31 $1.5M 191k 7.68

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Astria Therapeutics

Perceptive Advisors
RA Capital Management
Vestal Point Capital
Fairmount Funds Management
BlackRock
BlackRock
VR Adviser
TCG Crossover Management
Vanguard Group
State Street Corporation
Driehaus Capital Management
Geode Capital Management
Citadel Advisors
Affinity Asset Advisors
Nantahala Capital Management

View all funds holding Astria Therapeutics